Connection

Mark Rubinstein to Glucose Transporter Type 1

This is a "connection" page, showing publications Mark Rubinstein has written about Glucose Transporter Type 1.
Connection Strength

0.042
  1. Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells. J Biol Chem. 2019 06 07; 294(23):9198-9212.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.